Skip to main content
. 2019 Sep 25;12:1756284819878660. doi: 10.1177/1756284819878660

Figure 3.

Figure 3.

Overall survival according the sequence folfirinox followed by gemcitabine/nab-paclitaxel versus the reverse sequence in the whole and matched population.

CI, confidence interval; HR, hazard ratio.